Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

[Guidelines for type 1 Gaucher's disease].

Giraldo P; Grupo de Trabajo de las Guías de Actuación.

Med Clin (Barc). 2011 Sep;137 Suppl 1:55-60. doi: 10.1016/S0025-7753(11)70019-7. Spanish.

PMID:
22230128
2.

Gaucher's disease in Lithuania: its diagnosis and treatment.

Kleinotienė G, Tylki-Szymanska A, Czartoryska B.

Medicina (Kaunas). 2011;47(7):405-11.

3.

Treatment of Gaucher's disease with OGT 918.

Mistry PK.

Lancet. 2000 Aug 19;356(9230):676-7. No abstract available.

PMID:
10968454
4.

[Current development and usefulness of biomarkers for Gaucher disease follow up].

Maire I, Guffon N, Froissart R.

Rev Med Interne. 2007 Oct;28 Suppl 2:S187-92. Review. French.

PMID:
18228687
5.

[Therapeutic targets in Gaucher's disease].

Giraldo P, Roca M.

Med Clin (Barc). 2011 Sep;137 Suppl 1:46-9. doi: 10.1016/S0025-7753(11)70017-3. Spanish.

PMID:
22230126
6.

[Therapeutic objectives in Gaucher disease].

Mistry P, Germain DP.

Rev Med Interne. 2007 Oct;28 Suppl 2:S171-5. Review. French.

PMID:
18228683
7.

Gaucher's disease: a paradigm for interventional genetics.

Germain DP.

Clin Genet. 2004 Feb;65(2):77-86. Review.

PMID:
14984463
8.

Misdiagnosis of Niemann-Pick disease type C as Gaucher disease.

Lo SM, McNamara J, Seashore MR, Mistry PK.

J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S429-33. doi: 10.1007/s10545-010-9214-3. Epub 2010 Sep 30.

9.

Gaucher disease and its treatment options.

Bennett LL, Mohan D.

Ann Pharmacother. 2013 Sep;47(9):1182-93. doi: 10.1177/1060028013500469. Review.

PMID:
24259734
10.

Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.

van Dussen L, Hendriks EJ, Groener JE, Boot RG, Hollak CE, Aerts JM.

J Inherit Metab Dis. 2014 Nov;37(6):991-1001. doi: 10.1007/s10545-014-9711-x. Epub 2014 May 16.

PMID:
24831585
11.

Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.

Giraldo P, Pocoví M, Pérez-Calvo J, Rubio-Félix D, Giralt M.

Haematologica. 2000 Aug;85(8):792-9.

12.

[Molecular basis of treatment in Gaucher's disease].

Pocoví M.

Med Clin (Barc). 2011 Sep;137 Suppl 1:32-8. doi: 10.1016/S0025-7753(11)70014-8. Spanish.

PMID:
22230123
13.

Initiation of enzyme replacement therapy for an adult patient with asymptomatic type 1 Gaucher's disease.

Tanaka N, Saito H, Ito T, Momose K, Ishida F, Hora K, Kiyosawa K, Ida H.

Intern Med. 2001 Aug;40(8):716-21.

14.

Therapeutic goals in Gaucher disease.

Mistry P, Germain DP.

Rev Med Interne. 2006 Mar;27 Suppl 1:S30-8. English, French.

PMID:
16644400
15.

[Diagnosis, biomarkers and biochemical alterations in Gaucher's disease].

Gort L, Coll MJ.

Med Clin (Barc). 2011 Sep;137 Suppl 1:12-6. doi: 10.1016/S0025-7753(11)70011-2. Spanish.

PMID:
22230120
16.

Gaucher's disease and pregnancy.

Fasouliotis SJ, Ezra Y, Schenker JG.

Am J Perinatol. 1998 May;15(5):311-8. Review.

PMID:
9643638
17.

[New data on Gaucher's disease].

Stirnemann J.

Rev Med Interne. 2008 Mar;29(3):176-8. Epub 2007 Oct 5. French. No abstract available.

PMID:
17964006
18.

[Clinical outcomes of 2 pediatric patients with Gaucher's disease in enzyme replacement therapy for 9 years].

Quijada Fraile P, Martín Hernández E, Teresa García-Silva M.

Med Clin (Barc). 2011 Sep;137 Suppl 1:43-5. doi: 10.1016/S0025-7753(11)70016-1. Spanish.

PMID:
22230125
19.
20.

Gaucher's disease.

Patel AL, Shaikh WA, Khobragade AK, Soni HG, Joshi AS, Sahasrabudhe GS, Chole PV.

J Assoc Physicians India. 2009 May;57:410-1.

PMID:
19634291

Supplemental Content

Support Center